4-Aminopyridine CAS 504-24-5 Assay ≥99.5% (HPLC) Factory

Tsanangudzo Pfupi:

Zita reKemikari: 4-Aminopyridine

CAS: 504-24-5

Chiyero: ≥99.5% (HPLC)

Chitarisiko: Ichena kana Yellow Yellow Crystalline Powder

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Manufacturer Supply, High Purity, Commercial Production
Zita reKemikari: 4-Aminopyridine
CAS: 504-24-5

Chemical Properties:

Chemical Name 4-Aminopyridine
Mashoko anoreva zvakafanana 4-AP;4-Pyridinamine;Fampridine;Dalfampridine;p-aminopyridine;γ-Aminopyridine
Nhamba yeCAS 504-24-5
Nhamba yeCAT RF-PI539
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C5H6N2
Molecular Weight 94.12
Solubility Soluble muMvura, Ethanol
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Ichena kana Yellow Yero yeCrystalline Powder
Assay / Analysis Method ≥99.5% (HPLC)
Melting Point 157.0~162.0℃
Mvura (KF) ≤0.50%
Sulfated Ash ≤0.20%
2-Aminopyridine ≤0.10%
3-Aminopyridine ≤0.10%
Zvose Zvisina Kuchena ≤0.50%
Test Standard Enterprise Standard
Usage Pharmaceutical Intermediates;API

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.

Zvakanakira:

1

FAQ:

Application:

4-Aminopyridine (CAS: 504-24-5) imwe yeatatu isomeric amines ye pyridine, inonyanya kuchena, yakagadzirwa, uye biologically active compound, inoshandiswa zvakanyanya mukugadzirwa kwehupenyu, kusanganiswa kwemishonga yepakati uye Active Pharmaceutical Ingredient (API. ) synthesis.4-Aminopyridine (4-AP, Fampridine, Dalfampridine) inoshandiswa sechishandiso chekutsvakurudza mukuratidza subtypes ye potassium channel.Yakashandiswawo semushonga, kugadzirisa zvimwe zvezviratidzo zvemultiple sclerosis, uye inoratidzwa nezviratidzo zvekuvandudzwa kwekufamba muvakuru vane zvakasiyana-siyana zvechirwere.US Food and Drug Administration (FDA) yakabvumira komboni iyi musi wa22 Ndira, 2010. Fampridine inotengeswawo muUnited States neAcorda Therapeutics uye seFampyra muEuropean Union, Canada, neAustralia.

Nyora meseji yako pano ugotitumira